来自大豆的生物活性成分用于预防和干预肺癌
Tianzhu Guan1,2, Xiaoxiao Liu2, Longfei Zhang2
1College of Chemistry and Environmental Science, Laboratory of Xinjiang Native Medicinal and Edible Plant Resources Chemistry, Kashi University, Kashi, China.
豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆豆
科学领域:
- 营养科学 营养科学
- 在瘤学瘤学.
- 生物化学 生物化学
背景情况:
- 大豆 (Glycine max) 是一个重要的亚洲作物,富含蛋白质和生物活性化合物.
- 这些化合物,包括异黄和大豆素,具有潜在的健康益处.
- 大豆的生物活性成分调节关键的代谢途径,如MAPK,ER和NF-κB.
研究的目的:
- 系统地审查大豆衍生生物活性成分在肺癌中的作用.
- 探索它们在肺癌预防和治疗方面的潜力.
- 提供关于它们的机制和饮食干预潜力的见解.
主要方法:
- 对流行病学和临床证据的系统审查.
- 关于大豆植物化学物质和肺癌的科学文献分析.
- 检查分子作用机制的作用.
主要成果:
- 越来越多的证据支持大豆的抗癌潜力,特别是对抗肺癌.
- 大豆的生物活性化合物显示出调节癌症相关途径的能力.
- 这次审查是首次专门关注大豆对肺癌的影响.
结论:
- 来自大豆的生物活性成分在预防和治疗肺癌方面表现有前途.
- 了解它们的机制可以指导饮食干预.
- 需要进一步的研究来充分阐明它们的治疗潜力.
更多相关视频
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
08:03Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
Published on: December 1, 2016
相关概念视频
Cancer Prevention
Some...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Positive Regulator Molecules
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
